FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2807204637> ?p ?o ?g. }

• W2807204637 endingPage "89" @default.
• W2807204637 startingPage "83" @default.
• W2807204637 abstract "Background Whether or not non-vitamin K antagonist oral anticoagulants (NOACs) are associated with a lower risk of acute kidney injury (AKI) in patients with non-valvular atrial fibrillation (NVAF) remains unknown in real world practice. Methods In this nationwide retrospective cohort study, 1507, 3200, 5765 and 4227 NVAF patients with chronic kidney disease (CKD) and 4368, 16,945, 22,301, and 16,908 NVAF patients without CKD taking apixaban, dabigatran, rivaroxaban, and warfarin, respectively, from June 1, 2012 to December 31, 2016 were enrolled from the Taiwan National Health Insurance Program. Propensity-score weighted method was used to balance covariates across study groups. Patients were followed until occurrence of AKI or end date of study. Results Three NOACs were all associated with a significantly lower risk of AKI compared with warfarin for both CKD-free (hazard ratio, [95% confidential interval]; 0.65, [0.60–0.72] for apixaban; 0.68, [0.64–0.74] for dabigatran; 0.73, [0.68–0.79] for rivaroxaban) and CKD cohorts (0.50, [0.45–0.56] for apixaban; 0.54, [0.49–0.59] for dabigatran; 0.53, [0.49–0.58] for rivaroxaban). The annual incidence of AKI for all NOACs and warfarin increased gradually as the increment of CHA2DS2-VASc for both CKD-free and CKD cohorts after propensity score weighting. The reduced risk of AKI for three NOACs persisted in most subgroups in either CKD-free or CKD cohort. Multivariate analysis indicated that all three NOACs were all associated with lower risk of AKI than warfarin in either CKD-free or CKD cohort. Conclusions All three NOACs are associated with a lower risk of AKI than warfarin among Asians with NVAF in real-world practice." @default.
• W2807204637 created "2018-06-13" @default.
• W2807204637 creator A5007244502 @default.
• W2807204637 creator A5022908882 @default.
• W2807204637 creator A5035573488 @default.
• W2807204637 creator A5049753044 @default.
• W2807204637 creator A5054679498 @default.
• W2807204637 creator A5054836375 @default.
• W2807204637 creator A5062523096 @default.
• W2807204637 creator A5065190093 @default.
• W2807204637 creator A5069412202 @default.
• W2807204637 date "2018-08-01" @default.
• W2807204637 modified "2023-10-17" @default.
• W2807204637 title "The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan" @default.
• W2807204637 cites W1482390718 @default.
• W2807204637 cites W1972142091 @default.
• W2807204637 cites W1989098372 @default.
• W2807204637 cites W2008493502 @default.
• W2807204637 cites W2028161185 @default.
• W2807204637 cites W2032295354 @default.
• W2807204637 cites W2041524645 @default.
• W2807204637 cites W2048896102 @default.
• W2807204637 cites W2094924708 @default.
• W2807204637 cites W2095647706 @default.
• W2807204637 cites W2096710245 @default.
• W2807204637 cites W2107020336 @default.
• W2807204637 cites W2124691949 @default.
• W2807204637 cites W2130833207 @default.
• W2807204637 cites W2135694398 @default.
• W2807204637 cites W2144168223 @default.
• W2807204637 cites W2149388786 @default.
• W2807204637 cites W2151074096 @default.
• W2807204637 cites W2165242637 @default.
• W2807204637 cites W2320128544 @default.
• W2807204637 cites W2421809065 @default.
• W2807204637 cites W2521940263 @default.
• W2807204637 cites W2550043871 @default.
• W2807204637 cites W2556994020 @default.
• W2807204637 cites W2587045166 @default.
• W2807204637 cites W2768325747 @default.
• W2807204637 cites W594767912 @default.
• W2807204637 doi "https://doi.org/10.1016/j.ijcard.2018.02.075" @default.
• W2807204637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29885705" @default.
• W2807204637 hasPublicationYear "2018" @default.
• W2807204637 type Work @default.
• W2807204637 sameAs 2807204637 @default.
• W2807204637 citedByCount "33" @default.
• W2807204637 countsByYear W28072046372018 @default.
• W2807204637 countsByYear W28072046372019 @default.
• W2807204637 countsByYear W28072046372020 @default.
• W2807204637 countsByYear W28072046372021 @default.
• W2807204637 countsByYear W28072046372022 @default.
• W2807204637 countsByYear W28072046372023 @default.
• W2807204637 crossrefType "journal-article" @default.
• W2807204637 hasAuthorship W2807204637A5007244502 @default.
• W2807204637 hasAuthorship W2807204637A5022908882 @default.
• W2807204637 hasAuthorship W2807204637A5035573488 @default.
• W2807204637 hasAuthorship W2807204637A5049753044 @default.
• W2807204637 hasAuthorship W2807204637A5054679498 @default.
• W2807204637 hasAuthorship W2807204637A5054836375 @default.
• W2807204637 hasAuthorship W2807204637A5062523096 @default.
• W2807204637 hasAuthorship W2807204637A5065190093 @default.
• W2807204637 hasAuthorship W2807204637A5069412202 @default.
• W2807204637 hasConcept C126322002 @default.
• W2807204637 hasConcept C164705383 @default.
• W2807204637 hasConcept C167135981 @default.
• W2807204637 hasConcept C207103383 @default.
• W2807204637 hasConcept C2776301958 @default.
• W2807204637 hasConcept C2776704044 @default.
• W2807204637 hasConcept C2778653478 @default.
• W2807204637 hasConcept C2778661090 @default.
• W2807204637 hasConcept C2778810321 @default.
• W2807204637 hasConcept C2779161974 @default.
• W2807204637 hasConcept C2780472472 @default.
• W2807204637 hasConcept C2780638905 @default.
• W2807204637 hasConcept C44249647 @default.
• W2807204637 hasConcept C71924100 @default.
• W2807204637 hasConcept C72563966 @default.
• W2807204637 hasConceptScore W2807204637C126322002 @default.
• W2807204637 hasConceptScore W2807204637C164705383 @default.
• W2807204637 hasConceptScore W2807204637C167135981 @default.
• W2807204637 hasConceptScore W2807204637C207103383 @default.
• W2807204637 hasConceptScore W2807204637C2776301958 @default.
• W2807204637 hasConceptScore W2807204637C2776704044 @default.
• W2807204637 hasConceptScore W2807204637C2778653478 @default.
• W2807204637 hasConceptScore W2807204637C2778661090 @default.
• W2807204637 hasConceptScore W2807204637C2778810321 @default.
• W2807204637 hasConceptScore W2807204637C2779161974 @default.
• W2807204637 hasConceptScore W2807204637C2780472472 @default.
• W2807204637 hasConceptScore W2807204637C2780638905 @default.
• W2807204637 hasConceptScore W2807204637C44249647 @default.
• W2807204637 hasConceptScore W2807204637C71924100 @default.
• W2807204637 hasConceptScore W2807204637C72563966 @default.
• W2807204637 hasFunder F4320322108 @default.
• W2807204637 hasFunder F4320323441 @default.
• W2807204637 hasLocation W28072046371 @default.
• W2807204637 hasLocation W28072046372 @default.
• W2807204637 hasOpenAccess W2807204637 @default.

• next